Status:
COMPLETED
Usability of Blood Glucose Control With the Space TGC System in Medical ICU Patients
Lead Sponsor:
B. Braun Melsungen AG
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperglycemia is common in critically ill patients and associated with an adverse outcome. Thus, glycaemic control is an important issue in critical care. Despite extensive efforts of the intensive ca...
Eligibility Criteria
Inclusion
- Inclusion:
- Age: \> 18 years of age
- Stay in the ICU expected to be \> 72 h
- Blood glucose \> 6.1 mmol/L or patient on insulin treatment
- Exclusion:
- Patients with hyperglycaemic crisis/ketoacidosis due to insulin deficiency.
- Known or suspected allergy to insulin
- Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient (i.e., liver failure, other fatal organ failures)
- Moribund patients likely to die within 24 hours
Exclusion
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01164449
Start Date
July 1 2010
End Date
August 1 2011
Last Update
August 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zürich
Zurich, Switzerland, 8091